The Impact of Biological Factors on Gender and Health

Biology doesn’t treat everyone the same when it comes to health. Long before lifestyle choices, diet, or access to healthcare ever enter the picture, something more fundamental is already at work – our chromosomes and hormones. The biological differences between males and females shape disease vulnerability, cardiovascular risk, and even how long we live. Understanding these biological factors doesn’t mean reducing health to genetics, but it does mean recognizing that sex-based biology is a meaningful starting point for understanding why health outcomes differ so significantly across genders.

Genetic vulnerabilities: how your chromosomes affect your disease risk 🔗

Every human cell contains 23 pairs of chromosomes. The 23rd pair – the sex chromosomes – differs between biological males (XY) and biological females (XX), and this difference has real consequences for health. The X chromosome is gene-rich, carrying 867 known protein-coding genes that influence everything from brain function to heart tissue, bone, skin, and immune response. When one of these genes carries a harmful mutation, whether or not it causes disease depends significantly on whether you have one X chromosome or two.

Why males are more vulnerable to X-linked diseases 🔗

Males, with their single X chromosome, have no backup. Because the Y chromosome doesn’t contain most of the genes found on the X chromosome, it cannot protect males from a defective gene on their only X. This means that a single recessive mutation on the X chromosome is enough to cause a condition in a male. Females, by contrast, carry two X chromosomes. If one carries a mutation, the second, healthy copy can often mask or minimize its effects – making females carriers rather than sufferers of the disease.

This mechanism, known as X-linked recessive inheritance, explains why conditions like hemophilia A, Duchenne muscular dystrophy, red-green color blindness, and Fragile X syndrome occur far more frequently in males than females. In fact, at least 533 X-linked diseases are known to affect males more severely, most of which have nothing to do with reproduction – they affect the brain, heart, blood, kidneys, bones, skin, and more.

How females are protected – and when that protection fails 🔗

The protection females receive from their second X chromosome operates through a process called X-inactivation. In each cell, one of the two X chromosomes is randomly silenced. This means females have two populations of cells – some expressing one X and some expressing the other – creating a genetic mosaic that often dilutes the impact of a defective gene. Female carriers may sometimes show mild features of an X-linked condition due to skewed X-inactivation, but severe disease expression remains comparatively rare.

Importantly, this protection is not absolute. Females with Turner syndrome (who have only one X chromosome instead of two) lose this protective advantage and can experience X-linked conditions similarly to males. The broader takeaway is that having two copies of the X chromosome is one of the most significant biological buffers against a wide range of genetic diseases – and males simply don’t have it.

Hormonal influences on health: testosterone, estrogen, and the body 🔗

Beyond chromosomes, sex hormones play a powerful and sometimes paradoxical role in health. Testosterone and estrogen are not just reproductive hormones – they influence cholesterol levels, immune function, cardiovascular health, bone density, and aging itself. Their effects are complex, sometimes protective and sometimes harmful, and they change significantly over the course of a lifetime.

Testosterone and cardiovascular risk 🔗

Testosterone is the dominant sex hormone in males, and its relationship with cardiovascular disease has been studied extensively. Testosterone raises blood levels of LDL cholesterol (the “bad” kind) and lowers HDL cholesterol (the “good” kind), making males more prone to cardiovascular disease and stroke. This lipid-altering effect, combined with testosterone’s association with behavioral patterns like aggression and risk-taking, has led some researchers to describe the hormone’s cumulative downside as “testosterone toxicity.”

The picture is more nuanced than simple blame, however. Research shows that at normal physiological levels, testosterone does not straightforwardly damage the heart – and heart disease in women typically begins about 10 years later than in men, suggesting that the male hormone environment does accelerate cardiovascular aging even if testosterone alone is not the sole culprit. Additionally, nearly one in three adult men have some form of cardiovascular disease, a burden that researchers increasingly link to the interplay between testosterone, metabolic function, and aging.

Estrogen: a double-edged hormone 🔗

Estrogen, the primary sex hormone in females, has a notable reputation as a cardiovascular protector – and for good reason. During the pre-menopausal period, endogenous estrogen reduces oxidative stress and inflammation, which retards the aging of the cardiovascular system and contributes to better overall somatic fitness in middle-aged women compared to men. Estrogen raises HDL cholesterol, lowers LDL, and appears to have antioxidant properties at the cellular level, particularly in mitochondria.

But estrogen’s benefits come with a significant catch. After menopause, estrogen levels drop sharply, and cardiovascular disease risk rises steeply in women after age 50, with coronary artery disease accelerating around menopause. Post-menopausal women who have a hormonal profile that skews more androgenic – higher testosterone relative to estrogen – face a measurably elevated risk of cardiovascular disease and coronary heart disease. Furthermore, prolonged exposure to supplemental estrogen after menopause raises the risk of certain cancers, including uterine cancer, and increases rates of venous blood clots.

This hormonal shift after menopause also explains what researchers call the mortality-morbidity paradox: women live longer than men on average, but they often spend more years living with illness and disability – particularly later in life when estrogen’s protective effects have long faded.

Cross-species longevity: the female advantage isn’t uniquely human 🔗

One of the most compelling arguments for a biological basis of female longevity is that it is not exclusive to humans. It extends across much of the animal kingdom, suggesting something deeper is at work than social behavior or healthcare access.

What the data from mammals tells us 🔗

A comprehensive study drawing on data from the Species360 Zoological Information Management System – covering over 1,176 bird and mammal species in zoos worldwide – found that in 72% of mammal species, females lived longer, by an average of 12%. An earlier landmark study focused on wild mammals found that females lived an average of 18% longer than males across more than 60% of the 101 species studied – a gap considerably larger than the approximately 7.8% female longevity advantage seen in humans.

The pattern spans lions, orcas, gorillas, reindeer, whales, and many more. Critically, these differences persisted even in zoo environments where predation, food scarcity, and environmental stressors are largely removed – strongly suggesting that the longevity gap is not purely environmental. It endures even when life conditions are equalized.

The heterogametic sex hypothesis 🔗

A leading scientific explanation for this cross-species pattern is the heterogametic sex hypothesis. In mammals, males are the heterogametic sex – they carry two different sex chromosomes (XY), offering less genetic redundancy. Females, with their two identical sex chromosomes (XX), have a built-in backup for X-linked genes, which may confer a general biological durability advantage. This dual-chromosome pattern applies even in species without X and Y chromosomes – in birds, where females are the heterogametic sex (ZW) and males carry two identical chromosomes (ZZ), males often live longer. The pattern consistently tracks with which sex has chromosomal redundancy, not which sex is biologically female per se.

Beyond chromosomes, reproductive strategies matter too. In polygamous mammal species with intense male competition, males generally die earlier than females. The energy cost of developing secondary sexual traits – large antlers, aggressive body mass, competitive behaviors – takes a measurable biological toll. In primates especially, female longevity has likely been shaped by the evolutionary necessity of surviving long enough to raise offspring to independence.

Estrogen’s role in cross-species longevity 🔗

The hormonal layer reinforces the chromosomal one. Estrogens increase the expression of longevity-associated genes, including those coding for antioxidant enzymes, meaning mitochondria from females produce fewer reactive oxygen species than those from males. Oxidative stress is a central driver of cellular aging – and estrogen’s ability to dampen it may be one of the key reasons female mammals across many species consistently outpace their male counterparts in lifespan.

Putting it all together: biology as a foundation, not a destiny 🔗

The biological factors discussed here – X-linked genetic vulnerability, hormonal influences on cardiovascular and cellular health, and cross-species longevity patterns – establish that sex-based biology is a genuine and significant driver of health differences. Males face greater vulnerability to X-linked genetic diseases, a less favorable hormonal profile for cardiovascular health in youth, and a shorter average lifespan across most species studied. Females benefit from chromosomal redundancy and estrogen’s protective effects, though these advantages erode with age and come with their own health risks, including increased cancer susceptibility and sharper post-menopausal cardiovascular risk.

What biology establishes, however, is a foundation – not a fixed outcome. The gender gap in human longevity is one of the most robust features of human biology, present in 176 of 178 countries tracked by the United Nations, yet it is also narrowing in many societies as medicine and social conditions evolve. Biological vulnerability is real, but so is human adaptability. Understanding the biological starting points gives researchers, clinicians, and individuals better tools to address health disparities rather than simply accepting them.

What do you think? If biological factors like chromosomes and hormones contribute so significantly to health differences between males and females, how should healthcare systems adapt screening and treatment approaches to account for these built-in biological disparities? And given that the female longevity advantage is seen across dozens of mammal species, does knowing this change how you think about the relationship between biology and gender in everyday health decisions?

References

1. https://pmc.ncbi.nlm.nih.gov/articles/PMC7332419/
2. https://medlineplus.gov/ency/article/002051.htm
3. https://www.genome.gov/genetics-glossary/Sex-Linked
4. https://www.genomicseducation.hee.nhs.uk/genotes/knowledge-hub/x-linked-recessive-inheritance/
5. https://www.science.org/doi/10.1126/sageke.2005.23.pe17
6. https://www.health.harvard.edu/newsletter_article/mars-vs-venus-the-gender-gap-in-health
7. https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2020.00316/pdf
8. https://pmc.ncbi.nlm.nih.gov/articles/PMC2794431/
9. https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(22)00115-5/fulltext
10. https://www.acc.org/about-acc/press-releases/2018/05/30/09/08/sex-hormone-levels-may-affect-heart-disease-risk-in-post-menopausal-women
11. https://www.mpg.de/25470066/0926-evan-why-women-live-longer-than-men-150495-x
12. https://www.bath.ac.uk/announcements/scientists-investigate-why-females-live-longer-than-males/
13. https://www.sciencealert.com/theres-an-evolutionary-reason-why-female-mammals-live-longer
14. https://www.smithsonianmag.com/smart-news/females-live-longer-malesamong-humans-and-other-mammals-too-180974504/
15. https://pmc.ncbi.nlm.nih.gov/articles/PMC4932837/